Virtual ACC 2020 | Conscious Sedation in TAVR

According to the TVT Registry, patients who undergo transcatheter aortic valve replacement (TAVR) with conscious sedation have better outcomes, including lower mortality rates. A minimalist strategy always (sooner or later) proves to be superior across our whole range of procedures, from a simple diagnostic study with local anesthesia and a 4-Fr transradial access, to a transcatheter aortic valve replacement with percutaneous closure and conscious sedation.

This strategy is growing in the US, but in Europe it was adopted a while back.

Among interventional cardiologists, its adoption is as diverse as its definitions. However, pretty much everybody agrees on the use of transthoracic echocardiography and light sedation as a minimalist approach, as opposed to general anesthesia with an invasive management of the airway.

Only one trial to date, SOLVE-TAVI, randomized patients to one of the aforementioned strategies or the other, and it proved the noninferiority of a minimalist strategy. Such study, however, was underpowered to detect other events.


Read also: The Perks of Conscious Sedation in TAVR.


The analysis herein outlined was meant to be presented at the American College of Cardiology 2020 Scientific Session and simultaneously published in JACC: Cardiovascular Interventions. However, given the current worldwide pandemic, the event is unlikely to take place; in consequence, we can access this work digitally.

This study included 120,080 patients from over 500 sites, who underwent TAVR between 2016 and 2019. Globally, the proportion of patients managed through a minimalist strategy increased from 33% to 63%. Variation across sites was significant; one fourth of hospitals used conscious sedation in over 80% of procedures, and up to 13% of sites used general anesthesia in absolutely all cases.

Conscious sedation was associated with modestly lower in-hospital mortality (1.1% vs. 1.3% with general anesthesia; p = 0.01) and 30-day mortality (2.0% vs. 2.5%; p < 0.001).


Read also: TAVR in Extremely Large Annuli: Different Patients Might Need Different Prostheses.


The percentage of patients discharged home (88.9% vs. 86.1%; p < 0.001) and hospital length of stay (3.5 vs. 4.3 days; p < 0.001) were also significantly better with a minimalist approach.

Original Title: Conscious sedation versus general anesthesia for transcatheter aortic valve replacement: variation in practice and outcomes.

Reference: Butala NM et al. J Am Coll Cardiovasc Intv. 2020; Epub ahead of print.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Management of Valve Thrombosis in TAVI: Current Evidence-Based Approach

The expansion of transcatheter aortic valve implantation (TAVI) into younger and lower-risk populations has brought bioprosthetic valve thrombosis to the forefront as a clinically...

Experience with the intra-annular self-expanding Navitor valve: data from the STS/ACC TVT registry

The expansion of TAVI, with the introduction of new-generation devices, has prioritized not only periprocedural safety, but also the preservation of coronary access, more...

The Two Sides of the Coin: What Do CHAMPION-AF and CLOSURE-AF Teach Us About Left Atrial Appendage Closure?

Letter to the editor: Juan Manuel Pérez Asorey Percutaneous left atrial appendage closure (LAAO) is currently going through one of the most interesting stages of...

CLOSURE-AF: Percutaneous Left Atrial Appendage Closure versus Medical Therapy in Atrial Fibrillation

Percutaneous left atrial appendage closure has been proposed as an alternative to anticoagulation in patients with atrial fibrillation and high bleeding risk; however, comparative...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

High Ischaemic Risk Criteria in Chronic Coronary Syndrome: Prevalence and Prognosis

Despite advances in the management of chronic coronary syndrome (CCS), including the widespread use of drug-eluting stents (DES) and the optimization of medical therapy,...

Management of Valve Thrombosis in TAVI: Current Evidence-Based Approach

The expansion of transcatheter aortic valve implantation (TAVI) into younger and lower-risk populations has brought bioprosthetic valve thrombosis to the forefront as a clinically...

Experience with the intra-annular self-expanding Navitor valve: data from the STS/ACC TVT registry

The expansion of TAVI, with the introduction of new-generation devices, has prioritized not only periprocedural safety, but also the preservation of coronary access, more...